TEPANIL Drug Patent Profile
✉ Email this page to a colleague
When do Tepanil patents expire, and what generic alternatives are available?
Tepanil is a drug marketed by 3M and is included in two NDAs.
The generic ingredient in TEPANIL is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tepanil
A generic version of TEPANIL was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEPANIL?
- What are the global sales for TEPANIL?
- What is Average Wholesale Price for TEPANIL?
Summary for TEPANIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TEPANIL at DailyMed |
![TEPANIL drug patent expirations Drug patent expirations by year for TEPANIL](/p/graph/s/t/TEPANIL-patent-expirations.png)
US Patents and Regulatory Information for TEPANIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3m | TEPANIL | diethylpropion hydrochloride | TABLET;ORAL | 011673-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
3m | TEPANIL TEN-TAB | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 017956-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |